According to Reuters.com, “Valeant Pharmaceuticals has increased its takeover offer for Salix Pharmaceuticals to $10.96 billion in cash…bumping out Endo International Plc, the only other bidder for the maker of gastrointestinal drugs.” Salix has agreed to terms. For more details on this transaction, please visit: http://www.reuters.com/article/2015/03/16/us-salix-pharm-m-a-valeant-pharms-idUSKBN0MC16O20150316